Moving Beyond Aduhelm: Cell/Gene Therapy May Be ‘Poster Child’ For What Comes Next

 
• By Kate Rawson
  
Is gene therapy where FDA and CMS will be able to connect? • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock image

More from Medicare

More from Government Payers